Skip to main content
Home
  • Solutions
    Clinical solutions
    Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions
    Consulting & Commercial
    Asset Development Consulting Commercial Positioning Language Services Outcome Measures Real World Intelligence Regulatory Affairs Symphony Health data
    meeting
    Case studies

    Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.

    Innovative research tools showcase
    Technologies

    Technology solutions from early phase through to post-marketing.

  • Sectors
    Sectors

    ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

    Read more
    Biotech Government and Public Health Medical Device Pharmaceuticals
    Biotechnology services navigation panel
    Biotech

    Developing transformative therapies requires a flexible approach.

    Employee engagement program overview
    ICON and You

    Partners making a difference.

  • Therapeutics
    Therapeutics
    Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Hepatology Infectious Diseases Internal Medicine & Immunology Oncology
    Cross-therapeutics
    Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health
    Obesity 2025 insights image
    Obesity

    A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

    Biological research visual element
    Therapeutics insights

    ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.

  • Insights
    Insights
    Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel
    banners
    From bottlenecks to breakthroughs

    Human-centred strategies for faster study starts

    More than monitoring whitepaper
    More than monitoring

    How modern monitoring paradigms impact CRA roles

    digital globe network with icons
    Meeting requirements for Joint Clinical Assessments

    A planning guide for health technology developers

  • News & Events
    News & Events

    ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

    Read more
    Press releases In the News Mediakit Awards Events Webinars Social media
    webinar
    Best practices in global flow cytometry quality control and harmonisation

    5 March 2026. Register today.

    webinar
    When patients lead: Breaking barriers in ultra-rare disease drug development

    3 March 2026. Register today.

  • About ICON
    About ICON
    Company history ICON at a glance ICON in Asia Pacific ICON in Latin America Leadership Quality
    ICON for
    Patients Volunteers Investigators Jobs & Careers Investors Suppliers
    Responsible business practice indicators
    Sustainability, charity, inclusion and belonging

    ICON Cares is our commitment to making a positive impact on our people, environment and our community.

    Modern reception area at Dublin office
    ICON at a glance

    Delivering successful outcomes across the clinical development lifecycle.

  • Careers
  • Investors
  • Contact
  • 日本語
  • 简体中文
  1. Home
  2. News & Events
  3. Press releases
  4. ICON and its employees recognised as clinical research industry leaders, and for innovation and progress in sustainability

ICON and its employees recognised as clinical research industry leaders, and for innovation and progress in sustainability

Page tools
Share Share
Facebook

Share on Facebook

Facebook

Share on X

Facebook

Share on Linkedin

Bluesky

Share on Bluesky

Dublin, Ireland – 7 July 2025 – ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2025 with a number of business awards, recognising the company’s leadership position in the clinical research industry, cutting-edge innovation, its efforts in inclusion and sustainability, and as an employer of choice.

Acknowledging ICON’s leadership in the application of innovative AI technologies in the industry, the organisation won the AI Project of the Year Award at the Analytics & AI Awards. The award honoured ICON’s secure, enterprise-grade AI Assistant that streamlines work across functions, enabling faster insights, automating tasks, and scaling decision support through large language models (LLMs), with several agents live and thousands of global users onboarded.

ICON was also recognised as a Top-Rated Company for Women in the 2025 Ambition Box Employee Choice Awards. This recognition is based on feedback shared by ICON employees in India and reflects the inclusive culture the company strives to foster through its ongoing commitment to creating a workplace where women can thrive, lead, and grow.

In Asia Pacific, the company was awarded Best CRO in APAC at the 2025 Asia Pacific Biopharma Excellence Awards. The awards honour outstanding achievements in Asian bioprocessing, logistics, supply chain management, and clinical trials, celebrating current industry leaders while inspiring future innovators. ICON’s award recognises the organisation and its employees’ outstanding efforts and positive contribution in the APAC region.

At the PharmaTimes International Clinical Researcher of the Year awards, recognising the talent and passion of clinical researchers from across the globe, ICON boasted over 30 employees who received gold, silver, and bronze awards or who were nominated as finalists.

In recognition of the progress the company has made in sustainability, ICON was included on two TIME Magazine rankings: “World's Best Companies in Sustainable Growth 2025” and “World's Most Sustainable Companies 2025”. In the former list, which compiles companies who demonstrate both outstanding financial and environmental performance, ICON featured at number 57 out of 500 companies, and was listed as the highest CRO globally and the second highest Irish-based organisation. In the latter list, which ranks the world’s 500 most sustainable companies based on their public commitment to, and progress toward, sustainability targets, ICON was included as one of only four CROs, and one of nine Irish companies.

Steve Cutler, CEO, ICON commented: “These achievements once again recognise the dedication of our employees, who go above and beyond every day to deliver the best value to our customers. This is further reflected in the recognition our teams have received in the AI and sustainability space, and well-earned acknowledgement for how we are driving innovation for the future of clinical research and the planet.”

A full list of ICON’s industry awards can be viewed at www.iconplc.com/awards.

About ICON plc

ICON plc is a world-leading clinical research organisation powered by healthcare intelligence. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 41,250 employees in 97 locations in 55 countries as at March 31, 2025. For further information about ICON, visit: www.iconplc.com.


Media contacts:

Lisa Henry (GMT time zone)
Weber Shandwick (PR adviser)
+447785 458203
lhenry@webershandwick.com

ICON Press Office
iconnews@webershandwick.com

In this section
In this section
  • Press releases
  • In the News
  • Mediakit
    • Facts and figures
    • ICON spokespeople
  • Awards
  • Events
    • Industry events
    • Webinars
    • Workshops
  • Webinars
  • Social media

Connect with us

  • Contact us
  • Submit proposal request
  • Update Email Preferences
  • Global office locator
  • ICON on social media
Site Branding
    ICON plc
  • Contact
  • About ICON
  • Results & Reports
For Clients
  • Therapeutics
  • Solutions
  • Insights
  • Technologies
  • Content preferences
  • Office locations
ICON for
  • Patients
  • Volunteers
  • Investigators
  • Jobs & Careers
  • Investors
  • Suppliers
News & Events
  • Press releases
  • Mediakit
  • Events
  • Webinars
Socials
  • Linkedin
  • Facebook
  • Instagram
  • Youtube

Legal Footer

  • © 2026 ICON plc
  • Disclaimer
  • Privacy & Data
  • Cookies
How can we help?
  • All
  • Website
Popular search terms:
  • Biotech
  • Cell and Gene Therapies
  • Consulting
  • Early Clinical
  • Medical Device
  • Oncology
  • Rare & Orphan Diseases
  • Real World Evidence
  • Site & Patient Recruitment
  • Strategic Solutions
  • Regulatory Intelligence